Results 111 to 120 of about 70,663 (209)

Involvement of the hospital pharmacist in securing the chimeric antigen receptor (CAR)-T cell circuit. [PDF]

Eur J Hosp Pharm
Bryla A, Lorent S, Vervacke A, Scolas G, Alexandre L.   +4 more
europepmc   +1 more source

Chimeric antigen receptor (CAR) therapies for precise eradication of pathogenic cells in autoimmunity. [PDF]

Arthritis Res Ther
Kalliolias GD, Basdra EK, Papavassiliou AG.   +2 more
europepmc   +1 more source

Advancing Cancer Immunotherapy: Chimeric Antigen Receptor (CAR)-T Cell Engineering through Novel Screening Methods. [PDF]

Biomol Ther (Seoul)
Ha J, Seong J.
europepmc   +1 more source

Chimeric Antigen Receptor (CAR) T Cell Therapy for Neuromuscular Disorders: A Systematic Review. [PDF]

Cureus
Finsterer J.
europepmc   +1 more source

Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy vs. CD20xCD3 bispecific antibody as third- or later-line treatment in follicular lymphoma: a meta-analysis. [PDF]

Ann Hematol
Li X, Liao J, Liu S, Mo X, Wang B.
europepmc   +1 more source

Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review. [PDF]

Pharmacoecon Open
Patel N, Farid S, Gomes M.
europepmc   +1 more source

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation. [PDF]

Front Oncol
Feng S, Zheng P, Liu H, Sun M, Guo Y, Ma L, Liu R, Fu Z, Yang F, Ke X, Hu K.   +10 more
europepmc   +1 more source

m6A-Modified Nucleotide Bases Improve Translation of In Vitro-Transcribed Chimeric Antigen Receptor (CAR) mRNA in T Cells. [PDF]

Int J Mol Sci
Lao N, Li S, Ainciburu M, Barron N.
europepmc   +1 more source

Lymphoid and Myeloid Proliferations After Chimeric Antigen Receptor (CAR) T-Cell Therapy: The Pathologist's Perspective. [PDF]

Int J Mol Sci
Zhou J, Kelemen K.
europepmc   +1 more source

Elucidating HER2-directed chimeric antigen receptor (CAR) activation mechanism using homology modeling and all-atom molecular dynamics simulation. [PDF]

Comput Struct Biotechnol J
Hryb M, Davis L, Lao S, Paradis NJ, Staehle M, Mou X, Wu C.   +6 more
europepmc   +1 more source